These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
820 related articles for article (PubMed ID: 34758507)
21. Different corticosteroids and regimens for accelerating fetal lung maturation for babies at risk of preterm birth. Williams MJ; Ramson JA; Brownfoot FC Cochrane Database Syst Rev; 2022 Aug; 8(8):CD006764. PubMed ID: 35943347 [TBL] [Abstract][Full Text] [Related]
22. Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants. Shah SS; Ohlsson A; Halliday HL; Shah VS Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002057. PubMed ID: 29035425 [TBL] [Abstract][Full Text] [Related]
23. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. McGoldrick E; Stewart F; Parker R; Dalziel SR Cochrane Database Syst Rev; 2020 Dec; 12(12):CD004454. PubMed ID: 33368142 [TBL] [Abstract][Full Text] [Related]
24. Systemic corticosteroids for the treatment of COVID-19: Equity-related analyses and update on evidence. Wagner C; Griesel M; Mikolajewska A; Metzendorf MI; Fischer AL; Stegemann M; Spagl M; Nair AA; Daniel J; Fichtner F; Skoetz N Cochrane Database Syst Rev; 2022 Nov; 11(11):CD014963. PubMed ID: 36385229 [TBL] [Abstract][Full Text] [Related]
25. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Walters A; McKinlay C; Middleton P; Harding JE; Crowther CA Cochrane Database Syst Rev; 2022 Apr; 4(4):CD003935. PubMed ID: 35377461 [TBL] [Abstract][Full Text] [Related]
26. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Shepherd ES; Goldsmith S; Doyle LW; Middleton P; Marret S; Rouse DJ; Pryde P; Wolf HT; Crowther CA Cochrane Database Syst Rev; 2024 May; 5(5):CD004661. PubMed ID: 38726883 [TBL] [Abstract][Full Text] [Related]
27. Nasal high flow therapy for primary respiratory support in preterm infants. Hodgson KA; Wilkinson D; De Paoli AG; Manley BJ Cochrane Database Syst Rev; 2023 May; 5(5):CD006405. PubMed ID: 37144837 [TBL] [Abstract][Full Text] [Related]
28. Enteral zinc supplementation for prevention of morbidity and mortality in preterm neonates. Staub E; Evers K; Askie LM Cochrane Database Syst Rev; 2021 Mar; 3(3):CD012797. PubMed ID: 33710626 [TBL] [Abstract][Full Text] [Related]
30. Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome. Abdel-Latif ME; Davis PG; Wheeler KI; De Paoli AG; Dargaville PA Cochrane Database Syst Rev; 2021 May; 5(5):CD011672. PubMed ID: 33970483 [TBL] [Abstract][Full Text] [Related]
31. Early administration of inhaled corticosteroids for preventing chronic lung disease in very low birth weight preterm neonates. Shah VS; Ohlsson A; Halliday HL; Dunn M Cochrane Database Syst Rev; 2017 Jan; 1(1):CD001969. PubMed ID: 28052185 [TBL] [Abstract][Full Text] [Related]
32. Indomethacin for symptomatic patent ductus arteriosus in preterm infants. Evans P; O'Reilly D; Flyer JN; Soll R; Mitra S Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013133. PubMed ID: 33448032 [TBL] [Abstract][Full Text] [Related]
33. Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants. Onland W; Offringa M; van Kaam A Cochrane Database Syst Rev; 2012 Apr; (4):CD002311. PubMed ID: 22513906 [TBL] [Abstract][Full Text] [Related]
34. Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants. Mitra S; Scrivens A; von Kursell AM; Disher T Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013278. PubMed ID: 33301630 [TBL] [Abstract][Full Text] [Related]
35. Antenatal corticosteroids prior to planned caesarean at term for improving neonatal outcomes. Sotiriadis A; McGoldrick E; Makrydimas G; Papatheodorou S; Ioannidis JP; Stewart F; Parker R Cochrane Database Syst Rev; 2021 Dec; 12(12):CD006614. PubMed ID: 34935127 [TBL] [Abstract][Full Text] [Related]
36. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Roberts D; Brown J; Medley N; Dalziel SR Cochrane Database Syst Rev; 2017 Mar; 3(3):CD004454. PubMed ID: 28321847 [TBL] [Abstract][Full Text] [Related]
37. Superoxide dismutase for bronchopulmonary dysplasia in preterm infants. Albertella M; Gentyala RR; Paraskevas T; Ehret D; Bruschettini M; Soll R Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013232. PubMed ID: 37811631 [TBL] [Abstract][Full Text] [Related]
38. Caffeine dosing regimens in preterm infants with or at risk for apnea of prematurity. Bruschettini M; Brattström P; Russo C; Onland W; Davis PG; Soll R Cochrane Database Syst Rev; 2023 Apr; 4(4):CD013873. PubMed ID: 37040532 [TBL] [Abstract][Full Text] [Related]
39. Strategies for cessation of caffeine administration in preterm infants. Urru SA; Geist M; Carlinger R; Bodrero E; Bruschettini M Cochrane Database Syst Rev; 2024 Jul; 7(7):CD015802. PubMed ID: 39045901 [TBL] [Abstract][Full Text] [Related]
40. Caffeine versus other methylxanthines for the prevention and treatment of apnea in preterm infants. Moresco L; Sjögren A; Marques KA; Soll R; Bruschettini M Cochrane Database Syst Rev; 2023 Oct; 10(10):CD015462. PubMed ID: 37791592 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]